Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

NCT00003443 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: bryostatin 1

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]